References
- Agarwal R, Katare OP. 2002. Preparation and in-vitro evaluation of miconazole nitrate loaded topical liposomes. Pharm Tech,48–60, 2002. (Available at: http://www.pharmtech.com/data/artclestandard/pharmecch/462002/38265/article.pdf)
- Bhatia A, Kumar R, Katare OP. 2004. Tamoxifen in topical liposomes: development, characterization and in-vitro Evaluation. J Pharm Pharm Sci. 7:252–259.
- Dhillon V, Sharma S, Jain S, Arora S, Sharma A. 2011. Formulation characterization and evaluation of new topical 5-FU by drug entrapment in oleic acid vesicles. Am J Pharm Tech Res. 1:1–16.
- Downing DT. 1992. Lipid and protein structures in the permeability barrier of mammalian epidermis. J Lipid Res. 33:301–313.
- El Laithy HM, El-Shaboury KMF. 2002. The development of cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS Pharm Sci Tech. 3:1–9.
- Gebicki JK, Hicks M. 1973. Ufasomes are stable particles surrounded by unsaturated fatty acid membranes. Nature. 243:232–234.
- Golden GM, McKie JE, Potts RO. 1978. Role of stratum corneum lipid fluidity in transdermal drug flux. J Pharm Sci. 76:25–28.
- Gupta M, Vyas SP. 2012. Development, characterization and in-vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. Chem Phys Lipids. 165:454–461.
- Kaur IP, Kakkar S. 2010. Topical delivery of antifungal agents. Expert Opin Drug Deliv. 7:1303–1327.
- Li L, Redding S, Dongari BA. 2007. Candida glabrata, an emerging oral opportunistic pathogen. J Dent Res. 86:204–215.
- Maebashi K, Toyama T, Uchida K, Yamaguchi H. 1995. A novel model of cutaneous candidiasis produced in prednisolone -treated guinea pigs. J Med Vet Mycol. 19:390–392.
- Murakami MY. 1996. Effect of oleic acid vesicles on intestinal absorption of carboxyfluorescein in rats. Pharm Res. 3:35–41.
- Naik A, Pechtold LA, Potts RO, Richard HG. 1995. Mechanism of oleic acid-induced skin penetration enhancement in-vivo in humans. J Control Rel. 37:299–306.
- Pierre MBR, Tedesco AC, Marchetti JM, Bentley MVL. 2001. Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in-vitro permeation study. BMC Dermatol. 1–5, 2001. (Published online 2001 August 30. doi: 10.1186/1471- 5945-1-5).
- Satturwar PM, Fulzele SV, Dorle AK. 2005. Evaluation of polymerized rosin for the formulation and development of transdermal drug delivery system: a technical note. AAPS PharmSciTech. 6:649–654.
- Sharma A, Arora S. 2012. Formulation and in-vitro evaluation of ufasomes for dermal administration of methotrexate. ISRN Pharm. 2012:873653, 2012. (Published online June 12, 2012. doi: 10.5402/2012/873653).
- Souto EB, Muller RH. 2006. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul. 23: 377–388.
- Srisuk P, Thongnopnua P, Raktanonchai U, Kanokpanont S. 2012. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment. Int J Pharm. 427:426–434.